Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Jun 2017 16:03

RNS Number : 4761J
Marston's PLC
28 June 2017
Β 

Notification of interests of Directors and Persons Discharging Managerial Responsibilities

28 June 2017

The Company announces that on 28 June 2017 the Director listed below exercised an award over ordinary shares in the Company under the Company's 2014 Long Term Incentive Plan, which had been granted on 25 June 2014.

Shares were sold by the Director to the extent necessary to fund tax and NICs arising on the exercise as noted below.

Director

Aggregate number of shares in respect of which LTIP Award exercised*

Β 

Number of shares which were sold by the Director on 28 June 2017 at a price of Β£1.240118 per share

Andrew Andrea

57,907

27,313

Β 

\* The award granted on 25 June 2014 consisted of an LTIP Award and a "Linked Award", and a separate Approved Option over 20,876 shares at an exercise price of Β£1.437 per share. The Approved Option was released by the Director as part of the exercise process so that, in accordance with the rules of the LTIP the LTIP Award and Linked Award are capable of exercise to the extent vested.

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Enquiries: Anne-Marie Brennan, Group Secretary, Marston's PLC, +44 (0)1902 329163

Β 

1.

Details of PDMR / PCA (person closely associated)

Β 

(a)

Name

Andrew Andrea

Β 

(b)

Position/status

Director and PDMR (Chief Financial and Corporate Development Officer)

Β 

(c)

Initial notification/ amendment

Initial notification

Β 

2.

Details of the issuer

Β 

(a)

Name

Marston's PLC

Β 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

(a)

Description of the financial instrument

Ordinary shares of 7.375p each

Β 

ISIN GB00B1JQDM80

Β 

(b)

Nature of the transaction

Exercise of award under the Long Term Incentive Plan and sale of shares to fund tax associated tax liability

Β 

(c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

N/A

57,907

Β£1.240118

27,313

(d)

Aggregated information

Β 

Aggregated volume price

n/a single transaction

Β 

n/a single transaction

Β 

(e)

Date of the transaction

Β 

2017-06-28

(f)

Place of the transaction

Β 

London Stock Exchange, Main Market (XLON)

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHEASKPAEFXEFF
Date   Source Headline
3rd Dec 20247:00 amRNSPRELIMINARY RESULTS
16th Oct 20247:00 amRNSCapital Markets Day
9th Oct 20247:00 amRNSTrading update for the 52 weeks to 28 Sep 2024
23rd Sep 20248:58 amRNSHolding(s) in Company
2nd Sep 20243:55 pmRNSHolding(s) in Company
5th Aug 20243:19 pmRNSDirector/PDMR Shareholding
1st Aug 202412:09 pmRNSTotal Voting Rights
31st Jul 202410:41 amRNSCompletion of disposal of 40% stake in Brewing JV
30th Jul 202411:18 amRNSDirector/PDMR Shareholding
25th Jul 20242:50 pmRNSDirector/PDMR Shareholding
24th Jul 20247:00 amRNSTrading Update for the 42 weeks to 20 July 2024
10th Jul 20248:40 amRNSBlock listing Interim Review
8th Jul 20247:00 amRNSDisposal of 40% Stake in Brewing JV
4th Jul 20247:00 amRNSChair Appointment
14th Jun 20244:07 pmRNSHolding(s) in Company
14th May 20247:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 30 MARCH 2024
13th May 20243:42 pmRNSHolding(s) in Company
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.